Comparative Pharmacology
Head-to-head clinical analysis: COR OTICIN versus NUTRACORT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COR OTICIN versus NUTRACORT.
COR-OTICIN vs NUTRACORT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COR-OTICIN is a combination product containing hydrocortisone (a corticosteroid with anti-inflammatory and immunosuppressive properties) and neomycin (an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit) and polymyxin B (a polymyxin antibiotic that disrupts bacterial cell membrane permeability).
Corticosteroid receptor agonist; induces anti-inflammatory proteins and suppresses inflammatory mediators.
1-2 drops in each affected ear twice daily for 7 days.
One capsule (200 mg) orally twice daily with meals.
None Documented
None Documented
Terminal half-life 4-6 hours; prolonged in renal impairment (up to 12-15 hours)
Terminal half-life: 2-4 hours (mean 3 hours). Clinically, dosing every 6-8 hours maintains therapeutic levels.
Renal (60-80% unchanged), fecal/biliary (5-10%)
Renal (primarily as glucuronide and sulfate conjugates, <10% unchanged) and fecal (biliary excretion of metabolites). Approximately 70-80% renal, 20-30% fecal.
Category C
Category C
Topical Corticosteroid + Antibiotic
Topical Corticosteroid